About Meditect
Meditect is a company based in Paris (France) founded in 2017 by Romain Renard and Arnaud Pourredon. Meditect has raised $1.63 million across 3 funding rounds from investors including EIT Health, Bpifrance and Launch Africa. Meditect operates in a competitive market with competitors including RxAll, Saman Salamat, Veripad, TrueMed and TrueSpec-Africa, among others.
- Headquarter Paris, France
- Founders Romain Renard, Arnaud Pourredon
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.63 M (USD)
in 3 rounds
-
Latest Funding Round
Not available
-
Investors
EIT Health
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Meditect
Unlock access to complete
Unlock access to complete
Funding Insights of Meditect
Meditect has successfully raised a total of $1.63M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Meditect
Meditect has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include EIT Health, Bpifrance and Launch Africa.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund focused on tech companies
|
Locked | Locked | Locked | |
|
Private equity investments are made in France and the US.
|
Locked | Locked | Locked | |
|
Healthcare startups are accelerated and incubated through specialized programs.
|
Locked | Locked | Locked |
Investor details for Meditect
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Meditect
Investment portfolio details for Meditect
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Meditect
Detailed financials for Meditect
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Meditect Comparisons
Peer comparison for Meditect
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Meditect
Meditect operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as RxAll, Saman Salamat, Veripad, TrueMed and TrueSpec-Africa, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Medicines are authenticated via AI and spectrometers for pharmacy procurement.
|
|
| Locked | Locked | Locked |
Delivers comprehensive medicine tracking and tracing solutions to detect counterfeit drugs.
|
|
| Locked | Locked | Locked |
A digital tool for medication management tailored to healthcare providers.
|
|
| Locked | Locked | Locked |
Provides cloud and AI-based technology to healthcare providers for medicine validation
|
|
| Locked | Locked | Locked |
Delivers an AI-based device for verifying the genuinity of drugs.
|
Detailed competitors of Meditect
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Meditect
Complete news archive for Meditect
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Meditect
Meditect was founded in 2017 and raised its 1st funding round 2 years after it was founded.
Meditect is headquartered in Paris, France.
Arnaud Pourredon is the current CEO of Meditect. They have also founded this company.
Meditect is a funded company, having raised a total of $1.63M across 3 funding rounds to date.
Meditect was founded in 2017 in Paris, France, within the health technology sector. AI and blockchain-based software is developed to monitor the sale of counterfeit medicines. A mobile application is utilized by pharmacists and patients to scan products and verify authenticity through integrated scanning features. Operations center on enhancing pharmaceutical supply chain security across Europe.
Meditect's top competitors include RxAll, TrueMed and LambdaBlocks.
Meditect has 4 investors. Key investors include EIT Health, Bpifrance, Launch Africa, and LBO France.